4.4 Article

Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice

期刊

PSYCHOPHARMACOLOGY
卷 233, 期 3, 页码 447-456

出版社

SPRINGER
DOI: 10.1007/s00213-015-4129-1

关键词

Cognition; Learning and memory; Phosphodiesterase inhibitors; Phosphodiesterase-2; Object recognition test; Cyclic GMP; Cyclic AMP; Nitric oxide synthase; Protein kinase G; Soluble guanylyl cyclase

资金

  1. National Institute of Mental Health [MH088480]

向作者/读者索取更多资源

Rationale and objectives Cyclic nucleotide phosphodiesterase2 (PDE2) is a potential therapeutic target for the treatment of cognitive dysfunction. Using the object recognition test (ORT), this study assessed the effects of two PDE2 inhibitors, Bay 60-7550 and ND7001, on learning and memory, and examined underlying mechanisms. Methods To assess the role of PDE2 inhibition on phases of memory, Bay 60-7550 (3 mg/kg) was administered: 30 min prior to training; 0, 1, or 3 h after training; or 30 min prior to recall testing. To assess cyclic nucleotide involvement in PDE2 inhibitor-enhanced memory consolidation, either the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 20 mg/kg; intraperitoneal (IP)), soluble guanylyl cyclase inhibitor 1H-[-1,2,4] oxadiazolo-[4,3-a] quinoxalin-1-one (ODQ; 20 mg/kg; IP), protein kinase G inhibitor KT5823 (2.5 mu g; intracerebroventricular (ICV)), or protein kinase A inhibitor H89 (1 mu g; ICV) was administered 30 min prior to the PDE2 inhibitor Bay 60-7550 (3 mg/kg) or ND7001 (3 mg/kg). Changes in the phosphorylation of 3'5'-cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) at Ser-133 and vasodilatorstimulated phosphoprotein (VASP) at Ser-239 were determined to confirm activation of cAMP and 3' 5'-cyclic guanosine monophosphate (cGMP) signaling. Results Bay 60-7550 (3 mg/kg) enhanced memory of mice in the ORT when given 30 min prior to training, immediately after training, or 30 min prior to recall. Inhibitors of the cGMP pathway blocked the memory-enhancing effects of both Bay 60-7550 (3 mg/kg) and ND7001 (3 mg/kg) on early consolidation processes. Bay 60-7550 (3 mg/kg) enhanced phosphorylation of CREB and VASP, both targets of cGMP-dependent protein kinase (PKG). Conclusions These results confirm a potential of PDE2, or components of its signaling pathway, as a therapeutic target for drug discovery focused on restoring memory function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据